文献速递中医内科中药与中成药合理使用针灸推拿

韩医药治疗甲型肝炎康复一例:病例报告

Recovery from hepatitis A after Korean medicine-based treatment : a case report.
PubMed 文献 · Integr Med Res · 2019-11-07

一例39岁男性甲型肝炎患者住院12天,接受中药Chungganplus(CGP)每日三次、针灸每日两次及中脘穴艾灸每日一次治疗。12天后症状消失,肝功能指标持续改善,AST从1189 IU/L降至44 IU/L,ALT从2423 IU/L降至127 IU/L,总胆红素从3.6 mg/dL降至0.89 mg/dL,未见不良反应。作者认为韩医药为基础的治疗可能对甲型肝炎有效,但需进一步研究验证。

要点

  • CGP联合针灸、艾灸治疗12天使甲型肝炎症状消失。
  • AST、ALT、r-GTP、ALP及总胆红素均呈持续下降趋势。
  • 治疗期间未见不良反应报告。

核心结论

  • 韩医药为基础的治疗使用CGP可能对甲型肝炎有效且无不良反应。
  • 需要进一步研究和临床试验来验证CGP的疗效基础。

研究设计与样本

  • 病例报告:一例39岁男性甲型肝炎患者住院12天。
  • 干预:CGP每日三次,针灸每日两次,中脘穴(CV-12)艾灸每日一次。
  • 住院期间共进行4次随访血液检查以评估疗效。

主要发现

  • 12天内症状消失,血液检查结果稳步改善。
  • AST从1189 IU/L降至44 IU/L,ALT从2423 IU/L降至127 IU/L。
  • r-GTP从1347 IU/L降至339 IU/L,ALP从384 IU/L降至205 IU/L。
  • 总胆红素从3.6 mg/dL降至0.89 mg/dL。
  • 未报告不良反应。

临床怎么用

  • 本病例提示CGP联合针灸、艾灸可作为甲型肝炎的潜在治疗选择。
  • 治疗期间应通过系列血液检查监测肝功能指标变化。

局限性

  • 单例病例报告,证据级别有限,不能确立因果关系。
  • 作者指出需要进一步研究和临床试验验证CGP的疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many studies reported that Korean medicine (KM) is effective for treating liver disease, including hepatitis A. However, KM, specifically with herbal medicine (Chungganplus, CGP) has not been reported yet. We aimed to report a patient with hepatitis A who was treated with KM including CGP, acupuncture, and moxibustion for 12 days. METHODS: A 39-year-old man with hepatitis A who was hospitalized for 12 days after being admitted to our hospital with abdominal pain, diarrhea and vomiting. We prescribed CGP three times a day, with acupuncture performed twice daily and moxibustion at conception vessel (CV)-12 once a day. Follow-up blood tests have been done 4 times during the admission in order to access the effect of the treatment. RESULTS: In 12 days the symptoms had disappeared and the blood test results improved steadily. His AST level have declined from 1,189 IU/L to 44 IU/L, ALT from 2,423 IU/L to 127 IU/L, r-GTP from 1,347 IU/L to 339 IU/L, ALP from 384 IU/L to 205 IU/L, and total bilirubin from 3.6 mg/dL to 0.89 mg/dL. CONLCUSIONS: This case suggests that KM-based treatment using CGP may be effective for hepatitis A with no adverse effect. Further research and clinical trial on CGP would be needed to make the basis more valid.

来源:Integr Med Res,查看原文。版权归原作者所有。

引用

  1. Park CR, Lee G, Son CG, et al. Recovery from hepatitis A after Korean medicine-based treatment : a case report. Integr Med Res. 2019. PMID: 31768311. doi:10.1016/j.imr.2019.11.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。